Tenderwize
Retour à la recherche

Tiotropiumbromid (ATC R03BB04) excluding dry powder inhaler capsules

AOK Sachsen - Anhalt·Magdeburg, Germany·Deadline Mar 30, 2028 · 580 days left·Open·Supplies
Structured notice only
Titre original de l'avis

Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Tiotropiumbromid (ATC: R03BB04 - außer in der Darreichungsform HPI)

40/100

Score d'opportunité

Needs reviewLow complexity
SuppliesOpen
Pourquoi ce score ?

Opportunité

40 / 100

Complexité

20 / 100

Facteurs de risque

No estimated value or volume commitments; revenue depends on actual prescriptions and discount impact.

Notice explicitly states it is not a public procurement; legal recourse under GWB may be limited.

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 1 lot
  • Duration 2 YEAR
  • Supply of Tiotropiumbromid medicinal products (excluding dry powder inhaler capsules)
  • Conclusion of non-exclusive rebate agreements under German Social Code (§130a Abs. 8 SGB V)
Afficher le résumé complet

Non-exclusive discount agreement open-house model for Tiotropiumbromid (ATC R03BB04, excluding dry powder inhaler capsules) under §130a Abs. 8 SGB V. Any eligible pharmaceutical company can join anytime until contract end. Contract duration max 24 months from earliest start 01.06.2026, ending 31.05.2028. No procurement law application; voluntary transparency publication.

Risques

No estimated value or volume commitments; revenue depends on actual prescriptions and discount impact.

Notice explicitly states it is not a public procurement; legal recourse under GWB may be limited.

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Eligibility

  • Pharmaceutical company must be eligible to manufacture/market the product

Administrative

  • Complete and sign participation documents
  • Submit signed contract via qualified electronic signature or postal mail

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

No award criteria specified; all eligible participants are accepted.

Acheteur

Localisation

Magdeburg, DEU

Profil acheteur

Ouvrir le profil

Identifiant

DE258393558

Activité

Health

Lots (1)

LOT-0001

Tiotropiumbromid (ATC R03BB04) excluding dry powder inhaler capsules

Non-exclusive discount agreement for finished medicinal products containing Tiotropiumbromid (ATC R03BB04) in all dosage forms except hard capsules with powder for inhalation. Open-house model; each eligible pharmaceutical company can join at any time under identical conditions. No exclusivity, no individual negotiations. Contract ends 31.05.2028 regardless of start date.

SuppliesEU fundedElectronic submission

Localisation

DEE03, Germany

Durée

2 YEAR

Catégorie

Pharmaceutical products

Critères d'attribution

No award criteria specified; all eligible participants are accepted.

Date limite

Deadline Mar 30, 2028

Détails de la procédure

Date de publication
19 Apr 2026
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
266223-2026

Documents (1)

Appels d'offres similaires